InfuSystem Holdings, Inc. (INFU) News
Follow InfuSystem Holdings, Inc. (INFU) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
InfuSystem Beats Q3 Profit Estimates on Oncology, Wound Care Growth
InfuSystem reported Q3 profit above estimates, citing growth in oncology and wound care.
EQUITY | Nov 05, 2026, 11:48 AM UTC
M
InfuSystem Q3 Net Income Rises 40% to $3.16 Million
EARNINGS | Nov 05, 2026, 11:38 AM UTC
L
InfuSystem Holdings Reports Q3 EPS of $0.15
EARNINGS | Nov 05, 2026, 11:32 AM UTC
L
InfuSystem Holdings Reports Q3 Operating Income of $4.746 Million
EARNINGS | Nov 05, 2026, 11:32 AM UTC
M
InfuSystem Holdings Reports Q3 Revenue of $37.589 Million
EQUITY | Nov 05, 2026, 11:32 AM UTC
M
InfuSystem Announces Third-Quarter 2026 Financial Results
InfuSystem announced its third-quarter 2026 financial results. An investor conference call is scheduled for November 10, 2026, at 9:00 a.m. Eastern Time.
EQUITY | Nov 05, 2026, 11:31 AM UTC
M
InfuSystem Reports Q3 Gross Profit of $21.727 Million
EQUITY | Nov 05, 2026, 11:30 AM UTC
M
InfuSystem Holdings Reports Q3 Pretax Profit of $4.544 Million
EQUITY | Nov 05, 2026, 11:30 AM UTC
M
InfuSystem Postpones Q3 2026 Results, Reviews $4.2 Million in ERP Costs
InfuSystem said it postponed its third-quarter 2026 results release while completing reporting and reviewing the accounting treatment of $4.2 million in ERP implementation costs.
EQUITY | Nov 03, 2026, 01:15 PM UTC
M
Biotech Stocks Surge to 52-Week Highs on Strong Clinical Data
Several biotech stocks reached new 52-week highs on October 5, 2026, propelled by positive clinical research data and strong Phase 3 results. Vaxcyte Inc. (PCVX) saw a significant jump of 31%, while INFU and ILMN rose 7%
EQUITY | Oct 06, 2026, 07:52 AM UTC